Singapore markets open in 2 hours 32 minutes

BioAdaptives, Inc. (BDPT)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.00060.0000 (0.00%)
At close: 03:24PM EDT
Full screen
Loading interactive chart…
  • GlobeNewswire

    BioAdaptives, Inc. Welcomes Gimhana Dissanayake to Its Board of Directors

    We are confident that Gimhana’s leadership will significantly enrich our board’s talent and expertise, propelling us to new heights. LAS VEGAS, May 30, 2024 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT), a leader in the health and wellness sector, today announces the appointment of Gimhana Dissanayake to its Board of Directors. Gimhana, who currently serves as the vice president of operational sales for North America at The Hertz Corporation (NYSE: HTZ), brings over two decades o

  • GlobeNewswire

    BioAdaptives, Inc. Announces NaturaComplete™, an All-In-One Supplement to Optimize Its AI-Based FYO Obesity Management System

    LAS VEGAS, NV, Feb. 22, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTC: BDPT), a leading manufacturer and distributor of innovative, all-natural dietary supplements, announces the development on an All-In-One Dietary Supplement formula, NaturaComplete™, that provides a comprehensive array of over 70 vitamins, minerals, amino and fatty acids, trace minerals and other nutrients to support general health and obesity management activities. Some dietary methods and the use of cer

  • GlobeNewswire

    BioAdaptives Announces Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Mass Loss Reported With Obesity Management

    BioAdaptives, Inc. AI supported FYO Body Composition app Free FYO Body Composition Testing for First 100 Subscribers LAS VEGAS, NV, Feb. 01, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire –BioAdaptives, Inc. (OTC: BDPT), a leading manufacturer and distributor of innovative, all-natural dietary supplements, announces a new, Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Loss Reported with Obesity Management. The rising popularity and increased application of glucagon-like pep